The current management of primary breast cancer is based on a selective combination approach using surgery of lesser extent, radiotherapy and systemic therapy. It aims at achieving excellent locoregional control and improved survival with minimal morbidity. This article describes a rational approach to the management of primary operable breast cancer < 5 cm in size. Its success is measured by the rates of locoregional recurrence and long-term survival, which would be separately addressed. A brief discussion would also be made on the management of ductal carcinoma in situ and the follow-up policy for women after treatment of the primary cancer.